Complete endosonographic staging of lung cancer: a systematic single scope approach.

Complete endosonographic staging of lung cancer: a systematic single scope approach. - SCORE Sinlge scope complete staging of lung cancer with endosonography.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON39836

Enrollment

150

Registered

2013-03-06

Start date

2013-03-20

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: lung cancer indication for mediastinal staging resectable lung tumor patient is operable

Exclusion criteria

Exclusion criteria: distant metastases of lung cancer mediastinal lymph nodes not within reach of EBUS former lung cancer treatment

Design outcomes

Primary

Measure	Time frame
The main study parameter is the sensitivity for loco regional disease ( N2, N3, T4 disease) of complete endosonographic staging (by EBUS-TBNA and EUS-B-FNA) in comparison to EBUS staging alone.	—

Secondary

Measure	Time frame
1. Sensitivity for locally advanced disease (N2-3 metastases, T4) of systematic assessment and sampling of mediastinal lymph nodes in comparison to PET-CT directed assessment of the mediastinum (ie targeted approach). 2. The assessment of the left adrenal gland by EUS-B is feasible.	—

Countries

Netherlands

Outcome results